These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3546209)

  • 21. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH; Serrano C
    Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyponatremia syndrome in congestive heart failure].
    Nitter-Hauge S; Brodwall EK; Rootwelt K
    Tidsskr Nor Laegeforen; 1973 May; 93(13):916-9. PubMed ID: 4751587
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyponatremia induced by captopril in patients with congestive cardiac insufficiency. A report of 2 cases].
    Vitola D; Bittar AE; Junges F; dos Santos AA; Rodrigues R
    Arq Bras Cardiol; 1988 Dec; 51(6):463-5. PubMed ID: 3076356
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis: A case series.
    Kunin M; Ganon L; Holtzman EJ; Dinour D
    Nefrologia (Engl Ed); 2018; 38(1):87-91. PubMed ID: 28760437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correction of severe hyponatremia: slow or rapid?].
    Seifert A; Schaefer K
    Dtsch Med Wochenschr; 1991 Jun; 116(24):952-7. PubMed ID: 2044464
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of dilutional hyponatremia in congestive heart failure.
    Forssell G; Nordlander R; Orinius E
    Acta Med Scand; 1980; 207(4):279-81. PubMed ID: 7386223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
    Paterna S; Parrinello G; Amato P; Dominguez L; Pinto A; Maniscalchi T; Cardinale A; Licata A; Amato V; Licata G; Di Pasquale P
    Adv Ther; 1999; 16(5):219-28. PubMed ID: 10915397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rapid correction of hyponatremic states with PGA 1].
    Di Perri T; Forconi S; Pucceti F; Vittoria A; Guerrini M
    Boll Soc Ital Cardiol; 1975; 20(10):1251-8. PubMed ID: 1234423
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum and urinary magnesium during treatment of patients with chronic congestive heart failure.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):301-3. PubMed ID: 11714011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):265-8. PubMed ID: 11714003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemodynamic effects of the acute administration of captopril in refractory chronic congestive heart failure. Study of 13 patients and review of the literature].
    Dall'Aglio V; Rellini G; Charmet P; Cassin M; Variola A; Menin A; Manfroni A; Meneguzzo N; Bazzi A
    G Ital Cardiol; 1983 Sep; 13(9):153-9. PubMed ID: 6363191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of hyponatremia with increased renin activity in chronic congestive heart failure: impact of diuretic therapy.
    Schaer GL; Covit AB; Laragh JH; Cody RJ
    Am J Cardiol; 1983 Jun; 51(10):1635-8. PubMed ID: 6344606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
    Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hyponatraemia with captopril.
    Bortz J
    Nephron; 1986; 44(3):259-60. PubMed ID: 3537819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.